A Trulson
Overview
Explore the profile of A Trulson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trulson A, Beck M, Friederichs J, Wittenberg S, Schreiner A, Stuby F, et al.
Chirurg
. 2020 Jul;
91(10):813-822.
PMID: 32617613
In most cases periprosthetic fractures of the acetabulum are complex injuries and are extremely challenging for the treating medical team. Over the years the frequency of this overall rare entity...
2.
Trulson A, Bystrom J, Engstrom A, Larsson R, Venge P
Clin Exp Allergy
. 2007 Jan;
37(2):208-18.
PMID: 17250693
Background: The eosinophil is a cytotoxic cell and takes part in parasite killing and tissue-destructive processes by secretion of proteins such as eosinophil cationic protein (ECP). A polymorphism was demonstrated...
3.
Zagai U, Skold C, Trulson A, Venge P, Lundahl J
Clin Exp Immunol
. 2004 Mar;
135(3):427-33.
PMID: 15008974
Asthma is characterized by an eosinophilic inflammation and a subepithelial fibrosis in the airways. Eosinophils contain several cytotoxic substances, such as eosinophil cationic protein (ECP), which can promote inflammation and...
4.
Bystrom J, Tenno T, Hakansson L, Amin K, Trulson A, Hogbom E, et al.
APMIS
. 2001 Sep;
109(7-8):507-16.
PMID: 11552948
The eosinophil cationic protein (ECP) is a cytotoxic protein with ribonuclease activity, produced and stored in bone marrow eosinophil myelocytes. Mature circulating eosinophils contain about 10 pg ECP per cell....
5.
Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al.
Clin Exp Allergy
. 1999 Sep;
29(9):1172-86.
PMID: 10469025
No abstract available.
6.
Trulson A, Nilsson S, Venge P
Br J Haematol
. 1997 Aug;
98(2):312-4.
PMID: 9266926
The eosinophil activity in patients with renal cell adenocarcinoma during treatment with interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) was reduced when measured as zymosan-induced lucigenin-enhanced chemiluminescence (CL). Eosinophil cationic protein (ECP),...
7.
Trulson A, Nilsson S, Venge P
J Clin Pathol
. 1996 May;
49(5):381-5.
PMID: 8707951
Aims: To investigate the kinetics of normalisation of monocyte oxidative activity following tumour eradication. Methods: Whole blood lucigenin enhanced chemiluminescence was studied in patients with non-seminomatous germ cell tumours. Group...
8.
Trulson A, Nilsson S, BREKKAN E, Venge P
Inflammation
. 1994 Feb;
18(1):99-105.
PMID: 8206648
The production of oxygen metabolites is probably important in cancer cell killing. The production of the superoxide anion, O2-, can be measured by lucigenin-enhanced chemiluminescence (Cl). Previous studies have shown...
9.
Trulson A, Nilsson S, Venge P
Am J Clin Pathol
. 1989 Apr;
91(4):441-5.
PMID: 2929499
The production of oxygen-derived cytotoxic metabolites by phagocytic cells is probably important in cancer cell killing. This production can be measured by chemiluminescence (CL). In the present report the authors...